{"id":64781,"date":"2025-02-18T12:01:44","date_gmt":"2025-02-18T12:01:44","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/02\/18\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/"},"modified":"2025-02-18T12:01:44","modified_gmt":"2025-02-18T12:01:44","slug":"tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/","title":{"rendered":"TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference"},"content":{"rendered":"<div>\n<p align=\"justify\">WALTHAM, Mass., Feb.  18, 2025  (GLOBE NEWSWIRE) &#8212; TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced\u00a0that the Company will participate in a fireside chat at the H.C. Wainwright 3<sup>rd<\/sup> Annual Cell Therapy Virtual Conference on Tuesday, February 25, 2025 at 10:00 a.m. Eastern Time.<\/p>\n<p align=\"justify\">A webcast of the fireside chat will be available on the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3SeCteoDnX8kpAsjYBhWwtP1dDAn6VufHiB54tMm_up3d8A-wNL0nbkKtcP80ge7Fj-8dnmoxEi5_h8EXyhM_mW92hAUUaczE_8EdL-zHhA5tZTj2AeX7ga5m2S68ExA1gok1DhI7jHFGHh0Hm8FRAmM_Y34h9HEbk-kU8TFFyvhD4ala6X_WWKBqK1HdGWBGuGqgYvPMuEKrd60WqyzV0YB-FYx3Wvz8mzYGe77SJuHM7witN2ZHcy_y96PnxM60Geijow93lo86-x-yAhVBycaVaUDcyEsIVhYQ-P6fBv7hUm4FDKj1FUF0wVUYtxSjLGQR4l1NNgVFzizq_TD7w==\" rel=\"nofollow\" target=\"_blank\" title=\"Events and Presentations\">Events and Presentations<\/a>\u201d section of the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9Cnub7fjgndLgkRJ9uimkfAoHRTCfPjAGgH6JlTJNoVQXQVY_nukaKshlrRKKESJ3pGMsRkVpt6zpt56WnTmkEOEi80Pqk7cuIBtSisaRDx6vg-9w4ENiqvTERAATPP9g8Ss6_5RQ7FmUcXYsRmv1FJ8OumW3FsLG6Am9wc9Ohco-3MkvdIJfNeEWxRmV0FjIbVvtgzY4plhULP_qakRA9u1XJo6cllvemVQuga1FJI=\" rel=\"nofollow\" target=\"_blank\" title=\"ir.tscan.com\">ir.tscan.com<\/a>. An archived replay of the webcast will be available on the Company\u2019s website for 90 days following the event.<\/p>\n<p><strong>About TScan Therapeutics, Inc.<\/strong><\/p>\n<p align=\"justify\">TScan is a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer. The Company\u2019s lead TCR-T therapy candidates are in development for the treatment of patients with hematologic malignancies to prevent relapse following allogeneic hematopoietic cell transplantation (the ALLOHA&#x2122;\u00a0Phase 1 heme trial). The Company has developed and continues to expand its ImmunoBank, the Company\u2019s repository of therapeutic TCRs that recognize diverse targets and are associated with multiple HLA types, to provide customized multiplex TCR-T therapies for patients with a variety of cancers (the PLEXI-T<sup>TM<\/sup>\u00a0Phase 1 solid tumor trial). The Company is currently enrolling patients into both clinical programs.<\/p>\n<p><strong>Contacts<\/strong><\/p>\n<p>Heather Savelle<br \/>TScan Therapeutics, Inc.<br \/>VP, Investor Relations<br \/>857-399-9840<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F1XgWLr8ZOpBdmwK6xXcqa-RLIFE4N8kgw1x5h0-sHtek9v2yXHiRpdjOw-Ag9F3BlUAqkf3lOIP2eS9tWC0nQTHAe8OHG3QFD-oDqlhoZM4RM0NjGU3ItIiPuXLl1DXpndeUq9_1kBxRfBCQML_xcc8iRsgX4AHgUgoijnTaGcYrEMjed647U_LPtDeKLedzeZeMgW7xn61Gr8G8ednJlOyJw8r_N91TmOQHt-jKgcULK3MvqVrCPumfDx-Q4NrVIuzCX83OUcyJ_nhjlcXCIWaS4V7vWtTqqbX6uLDUzKgRhyBvOg35WqKuGoRvnOBo51LQIJn6J4-b_6AjGLh1lINCewHpE2xq0bCdXrpZUJ2zzM-xF2oL7594tRTGpqgs0ygpeQUtZaXZxLVn4rGnrIlKjF5Z7zKxFU3D4NCOU-ZNE86Wetx5OxVTRkYSKB8n0x106UOiukcItsztF3YYiADurNaCUL7uvbm4Bm3WGw=\" rel=\"nofollow\" target=\"_blank\" title=\"hsavelle@tscan.com\">hsavelle@tscan.com<\/a><\/p>\n<p>Maghan Meyers<br \/>Argot Partners<br \/>212-600-1902<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-ywVWOctcYz9JXrr9oi6P9kQ-A7OnkgSA9FiquBD6inU5dD_5NpXUQThpjXhk7BytH2_6litPrho3mQq5dzDq_sWi7YLqb-AaD9eYGqi3RM=\" rel=\"nofollow\" target=\"_blank\" title=\"TScan@argotpartners.com\">TScan@argotpartners.com<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODhhOGMwZTEtYzI5MC00NTBiLTk5YjQtOTg0YmNiN2RiYTNjLTEyMTg2MjI=\/tiny\/TScan-Therapeutics-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) &#8212; TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced\u00a0that the Company will participate in a fireside chat at the H.C. Wainwright 3rd Annual Cell Therapy [&#8230;]\n","protected":false},"author":1,"featured_media":64782,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-64781","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) &#8212; TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-18T12:01:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/TScan-Therapeutics-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference\",\"datePublished\":\"2025-02-18T12:01:44+00:00\",\"dateModified\":\"2025-02-18T12:01:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/\"},\"wordCount\":265,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/\",\"name\":\"TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-02-18T12:01:44+00:00\",\"dateModified\":\"2025-02-18T12:01:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference","og_description":"WALTHAM, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) &#8212; TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the","og_url":"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-02-18T12:01:44+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/TScan-Therapeutics-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference","datePublished":"2025-02-18T12:01:44+00:00","dateModified":"2025-02-18T12:01:44+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/"},"wordCount":265,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/","url":"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/","name":"TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-02-18T12:01:44+00:00","dateModified":"2025-02-18T12:01:44+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/tscan-therapeutics-to-participate-in-the-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64781","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=64781"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64781\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/64782"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=64781"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=64781"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=64781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}